Novartis

Novartis secures approval in China for Cosentyx

Read more

Novartis to manufacture anti-cholesterol drug Leqvio for US in Austria due to delay in US clearance

Read more

Novartis announces delivery of one billion courses of anti-malarial treatment

Read more

Novartis, Cadila Healthcare lead digital marketing space for ankylosing spondylitis in India: GlobalData

Read more

Novartis signs deal with iTheranostics to develop, commercialise compounds targeting FAP

Read more

Novartis in discussions to help produce COVID-19 vaccines, tests

Read more

US FDA declines approval for Novartis’ inclisiran

Read more

Novartis to acquire Cadent Therapeutics for $770 mn

Read more

Drug makers, BMGF pledge to strive for global access to COVID-19 diagnostics, therapeutics and vaccines

Read more

BioNTech to buy site from Novartis to boost COVID-19 vaccine production

Read more